Articles tagged "Liver"

2016 American Transplant Congress
Hematopoietic Progenitor Cells and Monocyte Subsets and Hepatic Decompensation in Patients Referred for Liver Transplant Evaluation.
K. Forde,¹ K. Krok,² M. Patel,¹ M. Krowka,³ M. Fallon,⁴ S. Kawut.¹
¹Medicine, University of Pennsylvania, Philadelphia, PA; ²Medicine, Penn State Hershey, Hershey, PA; ³Medicine, Mayo Clinic, Rochester, MN; ⁴Medicine, University of Texas Medical School – Houston, Houston, TX.
Background: Abnormal hepatic and systemic angiogenesis is an important component of advanced liver disease. Circulating hematopoietic progenitor cells (HPCs) and M2 monocytes are thought to…
2016 American Transplant Congress
Airway Inflammation and Symptoms in Children Following Liver and Heart Transplantation.
A. Redmann,¹ J. Bucuvalas,² R. Wood,³ C. Chin,⁴ C. Hart.¹
¹Otolaryngology, Cincinnati Childrens Hospital Medical Center, Cincinnati, OH; ²Pediatric Liver Care Center, Cincinnati Childrens Hospital Medical Center, Cincinnati, OH; ³Division of Pediatric Pulmonology, Cincinnati Childrens Hospital Medical Center, Cincinnati, OH; ⁴Heart Institute, Cincinnati Childrens Hospital Medical Center, Cincinati, OH.
Objectives: To describe the upper airway endoscopic findings of patients with stridor, stertor or sleep-disordered breathing after liver transplantation (LT) or heart transplantation (HT).Methods: Retrospective…
2016 American Transplant Congress
Utilization and Discard of HCV+ Donor Livers in the Advent of Direct-Acting Antiviral Therapy.
M. Bowring, L. Kucirka, A. Massie, X. Luo, M. Sulkowski, D. Segev, C. Durand.
JHU, Baltimore.
While 45% of liver candidates are hepatitis C (HCV)-antibody positive (+) and might benefit from a HCV+ donor liver, only a small proportion receive one.…
2016 American Transplant Congress
Systematic Review and Meta-Analysis of the Impact of Computed Tomography Assessed Skeletal Muscle Mass on Outcome in Patients Awaiting or Undergoing Liver Transplantation.
J. van Vugt,¹ S. Levolger,¹ R. de Bruin,¹ J. van Rosmalen,² H. Metselaar,³ J. IJzermans.¹
¹Surgery, Erasmus University Medical Center, Rotterdam, Netherlands; ²Biostatistics, Erasmus University Medical Center, Rotterdam, Netherlands; ³Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, Netherlands.
BackgroundAlthough liver transplant outcome has improved significantly, the shortage of human organs remains prevalent. Therefore, strict patient selection is of paramount importance. Recently, low CT-assessed…
2016 American Transplant Congress
Children Listed as Status 1B for Liver Transplantation Are Disenfranchised by MARS Therapy.
A. Bakshi,¹ M. Kueht,¹ A. Rana,^1,2 A. Akcan Arikan,³ J. Goss.^1,2
¹Surgery, Division of Abdominal Transplantation and Hepatobiliry Surgery, Baylor College of Medicine, Houston, TX; ²Surgery, Division of Abdominal Transplantation, Texas Children's Hospital, Houston, TX; ³Pediatric Medicine, Intensive Care, Texas Children's Hospital, Houston, TX.
Acute exacerbations of chronic liver failure in the pediatric population require advanced ICU care in order to survive to transplantation (OLT). Often, the patients are…
2016 American Transplant Congress
The mTORC2 Activation Is Critical for Hepato-Cytoprotection Against Ischemia and Reperfusion Injury.
H. Zhou,^1,2 J. Zhu,^1,3 S. Yue,¹ R. Busuttil,¹ J. Kupiec-Weglinski,¹ X. Wang,² Y. Zhai.¹
¹Surgery, David Geffen School of Medicine-University of California-Los Angeles, LA, CA; ²Liver Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China; ³Liver Surgery, Renji Hospital, Shanghai, China.
Background & AimsRapamycin and Everolimus have been used in liver transplant patients, particularly those with calcineurin inhibitor-related nephrotoxicity and hepatocellular carcinoma. Although designed as mTORC1…
2016 American Transplant Congress
The First 48 Months of an Australian Renal and Liver Organ Transplant Dermatology Database.
L. Ge,^1,2 P. Lowe.^1,2
¹Department of Dermatology, Royal Prince Alfred Hospital, Sydney, NSW, Australia; ²Faculty of Medicine, University of Sydney, Sydney, NSW, Australia.
PurposeThere have been few studies of non-melanoma skin cancers in the Australian cohort, a population unique for its high ambient UV radiation and sun-long lifestyle.…
2016 American Transplant Congress
The Incidence, Risk Factors and Clinical Course of De Novo Hepatitis B Infection in Pediatric Living Donor Liver Transplantation.
Z. Baris, F. Ozcay, G. Moray, M. Haberal.
Pediatric Gastroenterology, Baskent University, Ankara, Turkey; Pediatric Gastroenterology, Baskent University, Ankara, Turkey; Department of General Surgery, Baskent University, Ankara, Turkey; Department of General Surgery, Baskent University, Ankara, Turkey.
Aim: We evaluated the incidence, risk factors and clinical course of liver transplanted pediatric patients with de novo hepatitis B infection and the clinical course…
2016 American Transplant Congress
Clinical Significance of Solitary Pulmonary Nodules in Liver Transplant Recipients with Hepatocellular Carcinoma.
O. Serrano,¹ A. Bangdiwala,² D. Vock,² V. Kirchner,¹ K. Yadav,¹ A. Pugalendhi,¹ E. Minja,¹ T. Dunn,¹ E. Finger,¹ A. Matas,¹ R. Kandaswamy,¹ W. Payne,¹ T. Pruett,¹ S. Chinnakotla.¹
¹Surgery, Univ. of Minnesota, Minneapolis, MN; ²Biostatistics and Bioinformatics Core, Masonic Cancer Center, Minneapolis, MN; ³Biostatistics, Univ. of Minnesota, Minneapolis, MN.
PURPOSE: Currently, there are no guidelines for the management of solitary pulmonary nodules (SPN) in hepatocellular carcinoma (HCC) patients being evaluated for liver transplantation (LT).…
2016 American Transplant Congress
Fatty Liver in Non-Hepatic Organ Transplantation.
N. Kemmer, A. Alsina.
Tampa General Medical Group, Tampa, FL.
With the availability of effective antiviral regimen for HCV, Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in western countries and…